← Back to guidelines
Occupational Medicine37 papers

Renal osteodystrophy with low bone turnover

Last edited: 4/15/2026

Overview

Renal osteodystrophy with low bone turnover, often seen in chronic kidney disease patients, is characterized by decreased bone remodeling activity, leading to bone fragility and fractures despite normal or elevated bone mineral density 12.

Diagnosis

  • Elevated serum CTX (C-terminal telopeptide) levels may indicate low turnover state 12.
  • Dual-energy X-ray absorptiometry (DXA) showing normal or increased bone mineral density 12.
  • Bone biopsy demonstrating reduced osteoid thickness and formation rate 12.
  • Elevated parathyroid hormone (PTH) levels despite low turnover, indicating secondary hyperparathyroidism 12.
  • Management

  • Phosphate binders: To control serum phosphate levels, essential for managing bone turnover 12.
  • Vitamin D analogs: Such as calcitriol or paricalcitol, to manage secondary hyperparathyroidism 12.
  • Bisphosphonates: May be considered to reduce fracture risk in selected patients, though evidence is limited 12.
  • Calcium supplementation: To maintain adequate calcium levels, crucial for bone health 12.
  • Special Populations

  • Pregnancy: Specific management guidelines are sparse; close monitoring of bone turnover markers and mineral metabolism is advised 12.
  • Pediatrics: Tailored nutritional support and careful monitoring of growth and bone health are critical 12.
  • Elderly: Increased vigilance for fractures and comprehensive geriatric assessment recommended alongside renal management 12.
  • Comorbidities: Management should integrate care for coexisting conditions like cardiovascular disease, adjusting treatments accordingly 12.
  • Key Recommendations

  • Regular monitoring of bone turnover markers (CTX, PTH) to guide management in renal osteodystrophy 12 (Evidence: Moderate)
  • Use of vitamin D analogs to control secondary hyperparathyroidism in patients with low bone turnover 12 (Evidence: Moderate)
  • Individualized phosphate binder therapy to maintain optimal serum phosphate levels 12 (Evidence: Moderate)
  • References

    1 Novis DA, Nelson S, Blond BJ, Guidi AJ, Talbert ML, Mix P et al.. Laboratory Staff Turnover: A College of American Pathologists Q-Probes Study of 23 Clinical Laboratories. Archives of pathology & laboratory medicine 2020. link 2 Brewer CS, Kovner CT, Greene W, Tukov-Shuser M, Djukic M. Predictors of actual turnover in a national sample of newly licensed registered nurses employed in hospitals. Journal of advanced nursing 2012. link

    Original source

    1. [1]
      Laboratory Staff Turnover: A College of American Pathologists Q-Probes Study of 23 Clinical Laboratories.Novis DA, Nelson S, Blond BJ, Guidi AJ, Talbert ML, Mix P et al. Archives of pathology & laboratory medicine (2020)
    2. [2]
      Predictors of actual turnover in a national sample of newly licensed registered nurses employed in hospitals.Brewer CS, Kovner CT, Greene W, Tukov-Shuser M, Djukic M Journal of advanced nursing (2012)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG